5PSQ-001 Pharmacist intervention to improve the safety of patients treated with proton pump inhibitors
Background and importanceThe use of proton pump inhibitors (PPIs) to treat acid related disorders is increasing worldwide and this raises concerns. Accumulating evidence supports the increased risk of long term adverse events, such as fractures, chronic kidney disease (KD), hypomagnesaemia, Clostrid...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A150-A150 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!